EUnetCCC and BBMRI Join Forces to Strengthen Cancer Research Ecosystems

Leaders from EUnetCCC WP8, including task leads for Cancer Research (Task 8.2.3) and Precision Cancer Diagnostics (Task 8.2.4), recently engaged in a constructive discussion with delegates from with delegates from Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium (BBMRI-ERIC) and the associated partner canSERV Consortium to identify opportunities for strategic collaboration and to leverage synergies between the two organisations.

All participants agreed that forming a strategic partnership would be highly beneficial for both organisations to combine their expertise, share valuable resources, and align their efforts towards common goals in cancer research and biobanking. A Memorandum of Understanding is currently being prepared to formalise this collaboration.

Key objectives of the partnership

All participants agreed that forming a strategic partnership would be highly beneficial for both organisations. A Memorandum of Understanding is currently being prepared to formalise this collaboration.

• Standardised biobanking: Connecting biobanking activities at EUnetCCC institutions to the robust infrastructure provided by BBMRI-ERIC, ensuring standardised practices for both clinical and research purposes across Comprehensive Cancer Centres
• Enhanced data and sample sharing: Facilitating easier and more efficient sharing of data and samples among EUnetCCC institutions
• Mutual visibility: Both EUnetCCC and BBMRI-ERIC will work together to increase each other’s visibility through coordinated support and promotion

Opportunity: canSERV open call for cancer researchers

In related news, canSERV, a project led by BBMRI-ERIC that provides state-of-the-art cancer research services across Europe, has announced an open call for all cancer researchers. The deadline for applications is approaching soon: July 15th.

• What is offered: Free-of-charge access to services provided by the canSERV consortium members in all European countries
• Who should apply: Cancer researchers seeking to advance their projects with support from leading European infrastructures
• Why participate: This is a unique opportunity to leverage top-tier resources and expertise at no additional cost, accelerating progress in cancer research and paving the way for next-generation treatments

For more details, please see the official announcement on canSERV: canSERV Open Call